Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment

Rationale: Pulmonary exacerbations (PExs) are associated with significant morbidity in people with cystic fibrosis (CF). Severe PExs are treated with intravenous antibiotics, including tobramycin. CF care guidelines recommend continuing chronic maintenance medications during PEx treatment. Azithromy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ann Am Thorac Soc
Hauptverfasser: Cogen, Jonathan D., Faino, Anna V., Onchiri, Frankline, Gibson, Ronald L., Hoffman, Lucas R., Kronman, Matthew P., Rosenfeld, Margaret, Nichols, David P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Thoracic Society 2021
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869777/
https://ncbi.nlm.nih.gov/pubmed/32810412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.202002-176OC
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge